The FDA has approved the first generic versions of Johnson & Johnson's big-selling anticoagulant Xarelto, which brought in nearly $2.4 billion in US sales last year. The US regulator has cleared 2.5mg ...
In another move designed to reduce the US' reliance on imported medicines, the FDA has launched a pilot of fast-track reviews for generics tested and made in domestic facilities. According to the ...
Launched in 2017 as a challenger to React Native, Flutter has grown in popularity since, and now has a slightly greater share ...
Two solid-value approaches, one well-built ETF. Our research team assigns Gold ratings to strategies that they have the most conviction will outperform their Morningstar Category average over a market ...
Java 27 is now available, enabling G1 as the default garbage collector everywhere and bringing Compact Object Headers, TLS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results